www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Industries

Medicine trade tops $100b in 2015

By Wang Wen (China Daily) Updated: 2016-02-05 08:11

Medicine trade tops $100b in 2015

Employees arrange pills at a workshop owned by Beijing Tong Ren Tang Group Co Ltd, a traditional Chinese medicine maker.[Photo/Xinhua]

China's trade in medicines hit an all-time high of $102 billion last year.

The latest figures from the China Chamber of Commerce for Import and Export of Medicines and Health Products show the value was a 4.73 percent increase on 2014, and this year total export-import volumes are expected to rise again, by 3 to 5 percent.

Xu Ming, the chamber's deputy director, called the overall growth "healthy and stable", adding, however, that the Chinese export market had slowed.

Medicine imports were worth $46.2 billion, up 7.3 percent, while exports grew a slower 2.7 percent to $56.4 billion.

"That import growth indicates the Chinese domestic market has huge potential, as it is now the second-largest globally after the United States," said Xu.

The weaker export figures were largely indicative of an ongoing global economic slowdown, Xu said, and coupled with a weaker yuan, they put China on the back foot as an international medicine supplier.

Exports to the US performed well, even though some other main markets dropped. Volumes to the US grew 7.72 percent compared with the previous year and it is now China's second-largest medicine export market after Europe, where demand dropped 0.22 percent.

Xu remains positive that Chinese companies are making strong headway in their moves to expand trade abroad.

Some have been expanding through investment and merger, which is often a more complicated route than simply selling their products directly.

"It's astonishing how some Chinese companies have performed so well in overseas investments," Xu said.

One of the sector's most significant developments in 2015 was by a consortium led by Shanghai Fosun Pharmaceutical Group Co Ltd, which bought Ambrx Inc, a US biotechnology company focusing on molecular medicine.

The acquisition group also involved HOPU Jinghua (Beijing) Investment Consultancy Co Ltd, China Everbright Ltd's healthcare fund, and Wuxi PharmaTech, and the purchase included some valuable global biotechnology.

Fosun Pharma's Chairman Chen Qiyu said the acquisition would "produce a dramatic synergistic effect on Fosun's current development system".

Ambrx is now expected to build a global products development center in China, Chen said.

Other moves saw Chinese companies signing agreements with foreign companies to sell their products overseas.

Jiangsu Heng Rui Medicine Co Ltd, for instance, authorized US-based pharmaceutical company Incyte Corp to develop and sell its PD-1 antibody product outside China in September, with the Delaware firm paying $795 million for the right.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 美女黄网站 | 国产精品视频久久久久久 | 亚洲一区二区在线免费观看 | 国产成人黄网在线免 | 日本男人天堂 | 欧美一级毛片片免费 | 九九视频在线播放 | 久久com| 波多野结衣在线免费视频 | 高清一本之道加勒比在线 | 日本高清一本二本三本如色坊 | 国产乱淫a∨片免费视频 | 一级aaaaaa毛片免费同男同女 | 兔子先生节目在线观看免费 | 亚洲国产一级毛片 | 国产高清美女一级a毛片久久 | 一级毛片aaa | 99视频网| 欧美日本一区二区三区生 | 欧美在线黄色 | 日本天堂网址 | 中国a级淫片免费播放 | 免费人成在线 | 国产欧美在线一区二区三区 | 123成人网| 视频一区在线观看 | 欧美在线观看高清一二三区 | 欧美亚洲日本一区二区三区浪人 | 国产精品推荐 | 手机在线观看毛片 | 久久99国产综合精品 | 国产美女精品视频免费观看 | 这里只有精品国产 | 免费视频一区二区三区四区 | 亚洲欧美综合视频 | 91久久亚洲精品国产一区二区 | 日本三级香港三级乳网址 | 欧美专区在线视频 | 极品美女户外勾搭无套 | 国产日韩线路一线路二 | 日韩美女大全视频在线 |